VEGFA and neoplasm: Here, we show that an antibody directed against the C terminus of VEGF-A165 is able to inhibit VEGF-A165-mediated cell migration, angiogenesis and tumour growth in vivo and can be used to detect VEGF-A165 (but also presumably other VEGF-Axxx isoforms) in human plasma.